US EditionElevance Health (NYSE:ELV) Earns “Overweight” Rating from Cantor Fitzgerald
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Elevance Health (NYSE:ELV) Earns “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently has a $485.00 price target on the stock. Cantor Fitzgerald also issued estimates for Elevance Health’s FY2025 earnings at $34.47 EPS. Several other equities analysts have also recently […]
Elevance Health (NYSE:ELV) Given Outperform Rating at Royal Bank of Canada
Royal Bank of Canada restated their outperform rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $478.00 price target on the stock. Several other research analysts have also recently weighed in on the company. Stephens cut Elevance Health from an “overweight” rating […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
